Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
AN

ANGOStock

Nasdaq Global Select Market · Healthcare · US

$10.76 last close 2026-11-19
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment ANGO's does — no target price to set, unlike a price alert.

Near limit Ratio screen, 7 of 7 decided standards passing. MSCI Islamic is within 3 points of its line. Even if it crossed, the majority verdict would stay Compliant. What would change it

Sharia status
COMPLIANT
Per our in-house ratio engine · assessed 2026-08-31
7 of 7 pass our own screen — all 7 agree here
HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🟠 NOT YET
The main driver: insider selling on the open market. More negatives than positives right now. The setup isn't ready...
Scores: 1 bullish / 2 bearish
44
of 100
Setup confidence — system conviction, not win probabilityD

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

VWAP · SCALP
Entry
$15.43
Stop
$15.27
Target
$15.75
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 5 timeframes bullish · 91.3% aligned
VWAPPrice below VWAP ($11.36)
VolumeRelative volume 2.9× the 20-day average
Momentum10-day rate of change -4.7%
Overall readNOT YET

ANGO is currently considered halal (Sharia-compliant), per our in-house ratio engine (last assessed 2026-08-31). See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 433 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Wall Street consensus
BUY
10 analysts
Institutional own.
94.1%
of shares
Momentum (10d)
-4.7%
rate of change
SMC grade
D · 44
91.3% aligned
<0.01%
Non-permissible income — HTR, from filings (2026-05-31)
D · 44
SMC grade — 91.3% timeframe alignment
-4.7%
Rate of change (10d)
BUY
Wall Street consensus (10)
94.1%
Institutional ownership

How the status reached this point

Compliant · status tracked since Nov 17, 2026

No change to ANGO’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from our own screen, last on Nov 18, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-08-31. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $499.2M as of 2026-11-16. At the 2026-11-19 close it is about $473.5M (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing investments ratio would read 7.2% (6.8% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 2 of 2 ratios pass
RatioValueThresholdResult
Interest-bearing investments 6.81% 30.00% Pass(23.2pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Usmani Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing investments 14.04% 33.00% Pass(19.0pp buffer)
Non-liquid assets 67.40% at least 20.00% Pass(47.4pp above the floor)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Cash + interest-bearing securities 14.04% 33.33% Pass(19.3pp buffer)
Accounts receivable 32.60% 33.33% Pass(0.7pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
FTSE Pass 3 of 3 ratios pass
RatioValueThresholdResult
Cash + interest-bearing securities 14.04% 33.33% Pass(19.3pp buffer)
Accounts receivable 32.60% 50.00% Pass(17.4pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Dow Jones Islamic Market Pass 3 of 3 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Cash + interest-bearing securities 6.99% 33.00% Pass(26.0pp buffer)
Accounts receivable 9.24% 33.00% Pass(23.8pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
S&P Shariah Pass 3 of 3 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Cash + interest-bearing securities 8.16% 49.00% Pass(40.8pp buffer)
Accounts receivable 10.78% 49.00% Pass(38.2pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI M-Series Pass 3 of 3 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Cash + interest-bearing securities 8.16% 33.33% Pass(25.2pp buffer)
Accounts receivable 18.94% 49.00% Pass(30.1pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

MSCI Islamic Index (% of total assets)receivables ratio 0.7pts
AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
Usmani (% of total assets)non permissible income ratio 5.0pts

The numbers the ratios are built from

Read from ANGO's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $320.2M 2026-08-31 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtBorrowings — which definition was stored is not recorded not measured — —
Cash and interest-bearing securitiesCash, equivalents and marketable securities $34.0M 2026-08-31 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $241.9M 2026-08-31 Assets
Market capDenominator for AAOIFI $499.2M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $394.0M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $459.3M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-08-31 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet as of 2026-08-31. Income statement as of 2026-08-31. Screened 2026-11-16.

Filing links appear after the next screen: this row was screened before filing citations were recorded.

  • Total assets$241.9M
    Assets · balance sheet as of 2026-08-31
  • Cash and interest-bearing securities$34.0M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · balance sheet as of 2026-08-31
  • Receivables$44.9M
    AccountsReceivableNetCurrent · balance sheet as of 2026-08-31
  • Revenue$320.2M
    RevenueFromContractWithCustomerExcludingAssessedTax · income statement as of 2026-08-31
  • Interest income (non-permissible)$0
    no interest-income tag reported in 3+ years (treated as $0) · income statement as of 2026-08-31
  • Market cap$499.2M
    Market-data quote at screen time, 2026-11-16 · not a filing figure, so no link

What changed, and when

Verdict history for ANGO. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for ANGO has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

Tracked since 2026-09-07.

Revenue by business segment

How ANGO’s $320.2M of revenue for the fiscal year 2025-06-01 to 2026-05-31 splits across what it sells, as the company tags it in its own 10-K.

Fiscal year ended 2026-05-31
SegmentShareRevenue
Med Device 53.2% $170.2M
Med Tech 46.8% $150.0M

These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.

Source: 10-K filed 2026-07-14 (accession 0001628280-26-048138), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.

What would change the status

The headline verdict is the majority of the decided ratio standards — 7 pass and 0 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-08-31; market cap as stored on 2026-11-16.

Within 3 points of the line

MSCI Islamic is within 3 points of its line. Even if it crossed, the majority verdict would stay Compliant.

The ratios that move with the share price

AAOIFI's investments ratio (6.8% against a 30% line) would only fail if the market cap fell by 77%, to $113.2M. At the 2026-11-19 close it would read 7.2%.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Medical Instruments & Supplies listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
ISRGIntuitive Surgical Inc $132.3B —
ALCAlcon Inc. - Registered Shares $34.7B —
RMDResmed Inc. $33.5B —
WSTWest Pharmaceutical Services, Inc. $23.9B —
COOCooper Companies, Inc. $14.8B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold ANGO

8 of the 257 funds whose filed holdings we currently hold own ANGO shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns ANGO.

You may already own it

Widely held U.S. index funds. If you own one, you own ANGO through it. None of them is a Shariah fund; the last column is our look-through of each.

FundANGO in fundFund compliant by weight
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00% 54%
SCHB Schwab U.S. Broad Market ETF 0.00% 53%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.00% 54%
Other funds
FundANGO in fundFund compliant by weight
IWC iShares Micro-Cap ETF 0.11% 23%
STMSX SIMT Tax-Managed Small/Mid Cap Fund 0.06% 45%
JESIX Small Cap Index Trust 0.02% 31%
VEMPX VANGUARD EXTENDED MARKET INDEX FUND 0.01% 42%
JAFFX Total Stock Market Index Trust 0.00% 52%

Sorted by ANGO’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names ANGO once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding ANGO
InvestorFirmPositionWeightAs of
Chuck Royce Royce & Associates $30M 0.3% 2026-09-30
Steven Cohen Point72 Asset Management $15M 0.0% 2026-09-30
Peter Brown Renaissance Technologies $10M 0.0% 2026-09-30
Israel Englander Millennium Management $8M 0.0% 2026-09-30
First Eagle First Eagle Investment Management $5M 0.0% 2026-09-30
David Shaw D. E. Shaw & Co. $3M 0.0% 2026-09-30
Ken Griffin Citadel Advisors $2M 0.0% 2026-09-30
Louis Bacon Moore Capital Management $2M 0.0% 2026-09-30
Barrow Hanley Barrow Hanley Mewhinney & Strauss $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

16.1314.5212.9111.319.702025-11-202026-05-222026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
11.05
S2
11.23
S1
11.36
PIVOT
11.54
R1
11.67
R2
11.85
R3
11.98

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
13.78 – 16.44
±8.8% from 15.11, made 2026-10-04 · resolves 2026-10-11
SELL
from 19 indicators
78.7% of our last 25417 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.4% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsSTRONG BUY
4 buy · 1 neutral · 2 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)36.90NEUTRAL
Stochastic %K (14)8.44BUY
CCI (20)-197.78BUY
Williams %R (14)-91.56BUY
MACD (12,26,9)0.03BUY
ROC (10)-7.59SELL
Momentum (10)-0.93SELL
EMA (10)11.79SELL
SMA (10)11.86SELL
EMA (20)12.01SELL
SMA (20)11.98SELL
EMA (30)12.30SELL
SMA (30)11.79SELL
EMA (50)12.79SELL
SMA (50)13.20SELL
EMA (100)13.15SELL
SMA (100)13.94SELL
EMA (200)12.55SELL
SMA (200)12.57SELL

About ANGO

Healthcare · Medical Instruments & Supplies

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

angiodynamics.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-09-25

VWAP
Type · SCALP
15.43
Entry
15.27
Stop
15.75
Target
LOSS
Outcome · exit 15.27 (-1.04%)

Stop 15.27 Now 10.76 Target 15.75

Verdict

🟠 NOT YET

The main driver: insider selling on the open market. More negatives than positives right now. The setup isn't ready — check back when the trend or RSI changes.

Scores: 1 bullish / 2 bearish

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 64
⏰ 4H BEARISH 37
🕐 1H BEARISH 98
⏱ 15-Min RANGING 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-4.7%
Rate of change (10d)
2.9×
Volume vs its 20-day average
-0.38
MACD (no fresh cross)
$10.83
Volume POC (today)
$10.71 – $10.95
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

BEARISH   0 buys · 1 sells

Recent: Nighan Warren JR sold 64745 sh @ $14.72 (2026-07-30)

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.